Title: Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet‐B–narrow‐band
Abstract: Photodermatology, Photoimmunology & PhotomedicineVolume 19, Issue 1 p. 35-36 Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B–narrow-band J. P. Castanedo-Cazares, J. P. Castanedo-Cazares Department of Dermatology, Hospital Central, Universidad Autonoma de San Luis Potosi, MexicoSearch for more papers by this authorV. Lepe, V. Lepe Department of Dermatology, Hospital Central, Universidad Autonoma de San Luis Potosi, MexicoSearch for more papers by this authorB. Moncada, B. Moncada Department of Dermatology, Hospital Central, Universidad Autonoma de San Luis Potosi, MexicoSearch for more papers by this author J. P. Castanedo-Cazares, J. P. Castanedo-Cazares Department of Dermatology, Hospital Central, Universidad Autonoma de San Luis Potosi, MexicoSearch for more papers by this authorV. Lepe, V. Lepe Department of Dermatology, Hospital Central, Universidad Autonoma de San Luis Potosi, MexicoSearch for more papers by this authorB. Moncada, B. Moncada Department of Dermatology, Hospital Central, Universidad Autonoma de San Luis Potosi, MexicoSearch for more papers by this author First published: 12 March 2003 https://doi.org/10.1034/j.1600-0781.2003.00005.xCitations: 34Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Lepe V, Moncada B, Castanedo JP. A double-blind randomized trial of 0.1% tacrolimus versus 0.05% clobetasol for the treatment of childhood vitiligo. J Invest Dermatol 2002; 119: 342a . 2 Duncan JL. Differential inhibition of cutaneous T-cell mediated reactions and epidermal cell proliferation by cyclosporine-A, FK-506 and rapamycin. J Invest Dermatol 1994; 102: 84–88. 3 Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet-B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999–1003. 4 Meola T Jr., Soter NA, Lim HW. Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature. Arch Dermatol 1991; 127: 1708–1713. 5 Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet-A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001; 145: 472–475. Citing Literature Volume19, Issue1February 2003Pages 35-36 ReferencesRelatedInformation
Publication Year: 2003
Publication Date: 2003-02-01
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 47
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot